Carvedilol Tablet, Film Coated
Product Images NDC 68788-8252

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 68788-8252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carvedilol Tablets 3.125mg (3b56e0d0 82d7 4512 849f 2b72d7bae36e 00)

Label for Carvedilol Tablets 3.125 mg, film-coated oral tablets. The label highlights the generic name Carvedilol and states each tablet contains 3.125 mg of the active ingredient. Manufactured by Zydus Pharmaceuticals USA Inc., the label includes storage instructions, warnings, and a section for dosage directions in English and Spanish on a yellow background. The product NDC is not visible. Packaging details such as lot, batch, and expiration dates are blank.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)

Chemical structure of carvedilol, showing its molecular arrangement including an indole moiety and a methoxy-substituted phenyl group connected by a chain with hydroxyl groups and an amine.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)

A line graph comparing percent mortality over a period of 21 months between two groups labeled as "Placebo" and "Carvedilol." The y-axis represents percentage mortality from 0 to 30%, and the x-axis represents time in months from 0 to 21. The graph shows lower mortality in the Carvedilol group compared to the Placebo group, with a p-value of 0.0014 indicated.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)

A forest plot chart illustrating hazard ratios with confidence intervals for various patient subgroups, including gender, age, race, diabetic status, ischemic condition, heart rate, systolic blood pressure, and spironolactone use, as well as for all patients combined.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)

A line graph depicting percent mortality over 24 months comparing Carvedilol and placebo groups. The vertical axis shows percent mortality, while the horizontal axis represents months. The graph indicates lower mortality in the Carvedilol group compared to placebo, with a P value of 0.03.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)

A forest plot chart displaying hazard ratios for various patient subgroups and conditions related to cardiovascular health, such as age, sex, past myocardial infarction timing, beta blocker use, Killip class, thrombolytic therapy, angioplasty, congestive heart failure, angina, hypertension, diabetes, heart rate, and systolic blood pressure. The chart includes separate plots for different analyses with markers and confidence intervals around the hazard ratios.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.